Sompo Japan Nipponkoa Asset Management CO. LTD. lifted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 17.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 176,260 shares of the pharmacy operator’s stock after purchasing an additional 26,790 shares during the period. Walgreens Boots Alliance comprises about 2.1% of Sompo Japan Nipponkoa Asset Management CO. LTD.’s investment portfolio, making the stock its 9th biggest holding. Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings in Walgreens Boots Alliance were worth $8,064,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Islay Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $29,000. Americana Partners LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $29,000. Private Ocean LLC acquired a new stake in Walgreens Boots Alliance during the first quarter worth about $25,000. West Bancorporation Inc. acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $39,000. Finally, Pacifica Partners Inc. acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $42,000. 58.03% of the stock is currently owned by institutional investors and hedge funds.
Shares of Walgreens Boots Alliance stock traded down $0.15 on Friday, hitting $39.60. The company had a trading volume of 3,378,765 shares, compared to its average volume of 7,383,946. The business has a 50-day simple moving average of $42.22 and a 200-day simple moving average of $51.33. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. The company has a market cap of $34.87 billion, a PE ratio of 6.87, a PEG ratio of 1.83 and a beta of 0.55. Walgreens Boots Alliance Inc has a 52 week low of $36.65 and a 52 week high of $64.50.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.06. The business had revenue of $35.82 billion during the quarter, compared to analysts’ expectations of $35.24 billion. Walgreens Boots Alliance had a net margin of 2.52% and a return on equity of 21.26%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the firm posted $1.64 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Wednesday, May 20th will be issued a $0.4575 dividend. This represents a $1.83 annualized dividend and a dividend yield of 4.62%. The ex-dividend date is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.
Several research firms recently weighed in on WBA. Barclays dropped their price objective on shares of Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating on the stock in a research note on Friday, April 3rd. ValuEngine lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. BidaskClub lowered shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Friday, May 15th. SunTrust Banks dropped their price target on shares of Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating on the stock in a research note on Friday, April 3rd. Finally, Cowen dropped their price target on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating on the stock in a research note on Tuesday. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. The company presently has an average rating of “Hold” and an average price target of $51.21.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: Which market index is the best?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.